جست‌وجوی استاد و پژوهشگر

Anne Marie Mauricioمشاهده پروفایل

عضو هیئت علمی

• Implementation Science
• Family Interventions
• Public Health
• +۳ مورد دیگر

Anne Marie Mauricio is an Associate Research Professor in the Prevention Science department at the University of Oregon's College of Education. She serves as Associate Director of the Prevention Science graduate program and a clinical supervisor at the Child and Family Center's HEDCO Clinic. Her work bridges research and practice through the development, implementation, and evaluation of evidence-based family-centered interventions. Ph.D. in Counseling Psychology (APA Approved), Michigan State University (2001) M.A. in Counseling Psychology, Boston College (1993) B.A. in Psychology, Boston College (1990) Dr. Mauricio specializes in implementation science, focusing on the sustainable delivery of evidence-based interventions in real-world settings. Her research examines how cultural, sociodemographic, and contextual factors influence engagement in family-centered programs, and how heterogeneity in implementation readiness affects fidelity. Recent work addresses health equity in SARS-CoV-2 testing and vaccination for underserved populations. Her 15 most recent publications emphasize implementation frameworks (e.g., RE-AIM), digital health adaptations of the Family Check-Up, and social determinants of health in Latinx and vulnerable communities. Topics span pandemic response, behavioral interventions, and structural adaptations for equitable service delivery. Dissertation Award Program Grant, Blue Cross/Blue Shield of MI Foundation (2000) Dissertation Award, American Psychological Association (2001) NIMH Postdoctoral Research Fellow (2005-2007) NIMH Loan Repayment Recipient (2009-2013) Outstanding Faculty Mentor Award Nomination, Arizona State University (2017-2018) As a licensed psychologist, she maintains clinical practice in community mental health while leading federally funded grants focused on translating interventions into real-world systems. Her affiliations include Northwest Prevention Science (consultant/trainer) and leadership roles in adapting implementation competency drivers for provider training and fidelity monitoring.

• Women and substance use
• Hepatitis
• Harm reduction
• +۷ مورد دیگر

Professor Carolyn Day serves as Associate Dean (Research Education) at the Faculty of Medicine and Health , University of Sydney. She is affiliated with the Central Clinical School and specializes in Addiction Medicine . Carolyn has coordinated Addiction Medicine education (2007-2019) and continues her research at the Edith Collins Centre (Translational Research in Alcohol, Drugs and Toxicology) within Sydney Local Health District. PhD, National Drug and Alcohol Research Centre NHMRC post-doctoral fellowship, Kirby Institute Her research focuses on substance use harms , particularly for women and populations with infectious diseases like hepatitis. She explores harm reduction policies , social determinants of health, and treatment accessibility. Publications span opioid agonist therapy, hepatitis C care cascades, and gender-specific healthcare models. Recent articles examine regional health disparities in drug treatment, 24-hour syringe dispensing , and long-term impacts of supervised injecting . She collaborates with institutions like the Australian Professional Society for Alcohol and other Drugs (APSAD) and Public Health Association of Australia . Carolyn leads projects on reproductive healthcare for imprisoned women and opioid pharmacotherapies . She manages the peer-reviewed Drug and Alcohol Review and works with the Sydney Uniting Medically Supervised Injecting Centre as an Honorary Research Associate. Her work addresses systemic barriers to healthcare access and policy implementation in diverse populations.

Madeleine Leporeمشاهده پروفایل

استادیار

• Substance Use Disorders
• Psychiatric Disorders
• Mental Health Policy
• +۳ مورد دیگر

Madeleine Lepore, DNP, FIAAN, PMHNP-BC, serves as an Assistant Professor in the Health & Community Systems department at the University of Pittsburgh School of Nursing. Her clinical practice spans Western Psychiatric Hospital's Narcotic Addiction Treatment Program and Psychiatric Emergency Services, alongside Healing Bridges, a rural mental health community clinic. Dr. Lepore holds a Doctor of Nursing Practice (DNP) degree and maintains board certification as a Psychiatric-Mental Health Nurse Practitioner. Her research centers on mental health policy reform with dedicated advocacy for harm reduction strategies and syringe decriminalization. She investigates syringe service programs and integrated treatment models for co-occurring psychiatric and substance use disorders, aiming to transform addiction care across diverse populations and lifespan stages. Professional honors include: Fellow of the International Academy of Nursing (FIAAN) Dr. Lepore instructs the Community Clinical course, delivers Mental Health First Aid training, and consults for the Substance Use Disorder Certificate program. While actively engaged in clinical service and scholarly review activities—including editorial board membership for the Journal of Addictions Nursing and manuscript reviewing for nursing journals—no current student advising or research grants are documented in available sources. Her clinical teams at Western Psychiatric Hospital and Healing Bridges specialize in acute psychiatric intervention and community-based treatment for complex co-occurring disorders, emphasizing trauma-informed care in both emergency and rural settings.

• HIV Prevention
• Implementation Science
• Biostatistics
• +۵ مورد دیگر

Bo Wang is a tenured Professor at UMass Chan Medical School within the Department of Population and Quantitative Health Sciences. He holds multiple appointments across the T.H. Chan School of Medicine in the Departments of Emergency Medicine, Population and Quantitative Health Sciences (Division of Biostatistics And Health Services Research), and Psychiatry and Behavioral Sciences, as well as at the Morningside Graduate School of Biomedical Sciences in the MD/PhD Program. Dr. Wang's research focuses on HIV prevention, implementation science, and advanced statistical modeling. His work emphasizes theory-driven strategies to sustain HIV prevention in The Bahamas government school system, mHealth interventions for PrEP use and stigma reduction in Thailand, and improving self-management of HIV and substance use in Zambia. He serves on the NIH's SIHH Study Section (2023-2027) and has secured numerous NIH grants as PI or MPI for research in these areas. His recent publications demonstrate a strong focus on global health implementation science, with particular attention to HIV prevention strategies in resource-limited settings. His work spans multiple continents including The Bahamas, Thailand, Zambia, and Vietnam, addressing issues of stigma, adherence, and program fidelity in diverse cultural contexts. His research integrates advanced statistical methodologies including MOST/SMART designs and machine learning approaches for precision prevention. Dr. Wang's scholarly impact is evident through his extensive publication record and leadership on multiple NIH-funded projects, including R01, R34, and R21 mechanisms. His work bridges biostatistics, epidemiology, and implementation science to address critical gaps in HIV prevention and related health disparities across diverse populations.

Katja Trobergمشاهده پروفایل

پژوهشگر

• Addiction Medicine
• Substance Use Disorders
• Overdose Prevention
• +۳ مورد دیگر

Katja Troberg is a Researcher at Lund University's Faculty of Medicine, Department of Clinical Sciences, affiliated with the Clinical Addiction Research Unit within Psychiatry. Her work focuses on substance use disorders, particularly opioid dependence and overdose prevention strategies in the Swedish context. She actively contributes to research projects examining harm reduction interventions, treatment pathways, and healthcare access for individuals with substance use disorders. Her research interests center on addiction medicine , specifically examining overdose prevention through naloxone distribution programs, harm reduction strategies including needle exchange programs, and improving healthcare access for patients in opioid substitution treatment. Troberg investigates barriers to care, retention in treatment programs, and the epidemiological effects of public health interventions targeting substance use disorders. Her work often employs mixed methods approaches to understand both quantitative outcomes and qualitative patient experiences. The 14 research articles in her portfolio demonstrate consistent focus on opioid-related interventions, with recent publications (2022-2024) examining naloxone distribution effects on overdose mortality, patient experiences with take-home naloxone, treatment retention factors, and healthcare-seeking behaviors. Her work spans epidemiological studies, clinical trials, and mixed-methods research, primarily situated within Sweden's public health system with implications for international harm reduction strategies. Guldpillret 2023 - Awarded for significant contributions to addiction research and public health interventions Troberg serves as Joint second supervisor for PhD students researching effective interventions against opioid overdose, including emergency dispatching systems and volunteer responder protocols. She has participated in five major research projects, four of which are completed, focusing on naloxone distribution effects, treatment referral systems, and somatic health needs among patients in opioid substitution treatment. Her collaborative work involves multiple Swedish institutions and healthcare providers. As part of Lund University's Clinical Addiction Research Unit, Troberg contributes to a multidisciplinary team examining substance use disorders through clinical, epidemiological, and public health lenses. Her research directly informs Sweden's approach to harm reduction and treatment services, particularly regarding opioid dependence and overdose prevention strategies within the Scandinavian healthcare context.

• HIV
• Hepatitis C
• Implementation Science
• +۵ مورد دیگر

Nadine Kronfli, MD, MPH, FRCP(C), DTM&H is an Assistant Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the 5252 de Maisonneuve site. She is affiliated with the Infectious Diseases and Immunity in Global Health Program and the Centre for Outcomes Research and Evaluation (CORE). Dr. Kronfli's research focuses on designing, deploying, and evaluating evidence-based models of care to increase engagement along the HIV and hepatitis C virus care cascades for vulnerable populations, with particular emphasis on incarcerated and migrant populations. During the COVID-19 pandemic, her research expanded to include seroprevalence studies in correctional facilities and interventions to increase vaccine uptake among people in prison. Her work aims to support evidence-based policies to eliminate infectious diseases like hepatitis C and SARS-CoV-2 among neglected populations. Her recent publications demonstrate strong expertise in hepatitis C elimination among incarcerated populations, implementation science, and the intersection of infectious diseases with social determinants of health. Her research spans qualitative, quantitative, and mixed-methods approaches, with significant contributions to understanding barriers and facilitators in healthcare access for vulnerable groups. HIV care and treatment among vulnerable populations Hepatitis C elimination strategies Implementation science in correctional settings COVID-19 impacts on incarcerated populations Health disparities among migrants Dr. Kronfli's work has significant policy implications for infectious disease elimination efforts in Canada and globally, particularly regarding how to effectively engage marginalized populations in healthcare systems.

Emily van der Meulenمشاهده پروفایل

استاد

• Community-based methodologies
• Gendered surveillance studies
• Prison health and harm reduction
• +۴ مورد دیگر

Dr. Emily van der Meulen is a Professor in the Department of Criminology at Toronto Metropolitan University (TMU), Faculty of Arts. She holds a PhD in Women’s Studies from York University (2009) and has held postdoctoral fellowships at St. Michael’s Hospital and the University of Toronto’s Munk School of Global Affairs. Her work focuses on gendered surveillance, prison health, sex work criminalization, and anti-human trafficking policies. She has conducted groundbreaking research on carceral syringe distribution, CCTV surveillance impacts, and migrant sex workers’ healthcare access. Her research employs community-based methodologies and addresses systemic issues like drug law enforcement’s moral injury, stigma in prison needle exchange programs, and therapeutic alignments between police and public health agencies. She has been awarded TMU’s Faculty of Arts Scholarly Award three times (2013, 2019, 2022). Collaborations include the HIV Legal Network, PASAN, and Butterfly. She teaches courses like Qualitative Research Methods and Gender, Sexuality, and the Law. Her publications critically examine carceral systems, drug policies, and the intersections of law and harm reduction. Current projects include analysis of Canada’s Temporary Foreign Worker Program labor exploitation narratives and the political framing of trafficking discourses.

• Community mental health
• Psychosis
• Suicidality
• +۶ مورد دیگر

Peter L. Phalen, PsyD, is an Assistant Professor in the Department of Psychiatry at the University of Maryland. His work focuses on improving community mental health through clinical services and addressing public health challenges like gun violence and stigma. He leads an NIMH-funded randomized controlled trial of Dialectical Behavior Therapy (DBT) for psychosis and suicide prevention and collaborates on projects related to early psychosis care, trauma care for gun violence victims, and opioid harm reduction. Research Keywords: Community mental health, psychosis, suicidality, gun violence, stigma, Bayesian data analysis Clinical Keywords: Dialectical Behavior Therapy, trauma care, early psychosis intervention Recent Research Trends: Dr. Phalen's publications emphasize psychosis and suicidality, with methodological strengths in Bayesian modeling, systematic reviews, and telehealth interventions. His work spans early psychosis screening, firearm violence prevention, and substance use disorder treatment outcomes. Scientific Awards: NIJ Recidivism Forecasting Challenge Winner (2021). Grants: NIMH, ATIP, and VA Capitol Healthcare Network funding. Clinical Practice: Dr. Phalen is a Licensed Psychologist providing personalized care for individuals with psychosis-like symptoms and suicidal ideation. He advocates for integrating lived experience into research and clinical practice.

Yesenia Aponte-Meléndezمشاهده پروفایل

پژوهشگر

• Sociology
• Public Health
• Substance Abuse
• +۵ مورد دیگر

Yesenia Aponte-Meléndez is a Researcher at the Institute for Society, Psychology, and Health (ISPH), affiliated with The New School for Social Research . Her work bridges sociology and public health, focusing on technology-delivered interventions for substance use disorders and infectious disease prevention among people who inject drugs. Co-founded El Punto en la Montaña, a syringe exchange program in Puerto Rico Conducts qualitative and clinical research on HIV/Hepatitis C syndemics and harm reduction Specializes in migrant Puerto Rican health disparities in NYC and Puerto Rico Her research explores the intersection of social class , gender , and prescription opioid misuse , combining mixed-methods approaches with policy-oriented outcomes. Recent work addresses xylazine-fentanyl overdoses and healthcare cost barriers in syringe service programs. Publications demonstrate a longitudinal focus on digital health solutions in methadone maintenance treatment and behavioral therapy for substance use disorders. Key sub-fields include harm reduction infrastructure, syndemic theory, and stigma mitigation in medical systems.

Fatema Z. Ahmedمشاهده پروفایل

پژوهشگر ارشد

• Health Policy
• Health Services Research
• Substance Use Disorders
• +۳ مورد دیگر

Fatema Z. Ahmed is a Postdoctoral Scholar at the University of Central Florida's School of Global Health Management and Informatics, conducting critical research at the nexus of health policy, substance use disorders, and criminal justice systems. Education: Ph.D. in Public Affairs, specializing in global and community health services research MHA (Master of Health Administration) Research Focus: Dr. Ahmed's work centers on health policy and health services research , with specialized expertise in substance use disorders among vulnerable populations. Her research investigates how state Medicaid policies impact access to Medications for Opioid Use Disorder (MOUD) for criminal justice-involved individuals, while examining media framing of addiction treatments and barriers within problem-solving courts. As a core member of the Substance Use Policy Evaluation and Research (SUPER) workgroup, she drives evidence-based policy solutions through rigorous mixed-methods analysis. Publication Trends: Her 15 recent publications (2020-2025) demonstrate a cohesive research trajectory focused on opioid use disorder within criminal justice contexts, policy impacts on treatment access, and media influence on public perception. Methodologically sophisticated, her work combines survey experiments, policy analysis, and qualitative assessments to address systemic barriers in addiction treatment. Scientific Recognition: National Institute of Drug Abuse (NIDA) research funding Doctoral Research Support Award (UCF College of Graduate Studies) Graduate Dean's Dissertation Completion Fellowship (UCF College of Graduate Studies) Research Leadership: Dr. Ahmed actively shapes substance use policy through the SUPER workgroup, where she collaborates on multi-institutional studies examining syringe services programs, court-based interventions, and health equity initiatives. Her work directly informs legislative efforts to expand evidence-based addiction treatment within justice systems.

M.H. Clarkمشاهده پروفایل

عضو هیئت علمی

• Causal Inference
• Experimental Designs
• Applied Statistics
• +۳ مورد دیگر

M.H. Clark, Ph.D., is an Associate Lecturer at the Department of Learning Sciences and Educational Research, College of Community Innovation and Education, University of Central Florida (UCF). She specializes in causal inference, selection bias in non-randomized experiments, and propensity score methods. As a statistical consultant and program evaluator, she teaches graduate courses in statistics and research methods, coordinates the Computing and Statistical Technology Laboratory in Education (CASTLE), and contributes to the UCF Court Health Services and Policy Workgroup. She also collaborates with the Program Evaluation and Educational Research Group. Education: Ph.D. in Experimental Psychology (Research Design and Statistics), University of Memphis Her research focuses on causal inference, propensity score methods, and their applications in education and public health. Recent work examines substance use disorder treatment in judicial systems, program evaluation in educational settings, and behavioral interventions for early childhood education. Her publications span topics like police chief attitudes toward opioid interventions, sedentary behavior reduction in kindergartens, and disparities in overdose reporting. Clark’s articles demonstrate expertise in propensity score adjustments, program evaluation, and policy analysis. Her collaborations include the UCF Court Health Services and Policy Workgroup and CASTLE, where she provides statistical consultation. She actively presents at the American Evaluation Association conventions. Professional Affiliations: Member of the American Evaluation Association

Karyn Heavnerمشاهده پروفایل

استاد آموزشی

• HIV/AIDS
• Viral Hepatitis
• Harm Reduction
• +۳ مورد دیگر

Karyn Heavner is an Associate Teaching Professor in the Department of Public Health at the University of Massachusetts Lowell's Zuckerberg College of Health Sciences. She holds a Ph.D. in Epidemiology from the University at Albany (2007), an MSPH in Epidemiology from the University of South Carolina (2001), and a B.A. in International Corporate Communications from the American University of Paris (1999). Her postdoctoral training includes fellowships in harm reduction at the University of Alberta and autism epidemiology at Drexel University. Dr. Heavner's research spans: HIV/AIDS epidemiology and prevention strategies Harm reduction interventions for substance use disorders Viral hepatitis transmission dynamics Advanced epidemiological methods including survey design and database analysis Autism spectrum disorder risk factors Environmental and occupational health impacts Her 15 most recent publications demonstrate strong methodological focus, with 60% addressing epidemiological techniques like measurement error analysis and statistical simulations. Substance use and harm reduction constitute 33% of her recent work, while environmental oncology and perinatal health each feature in prominent studies. Honors: Sin Ming Shaw Award for Research (1999) She directs community initiatives including establishing New Hampshire's syringe services program and collaborates with the New Hampshire Harm Reduction Coalition. Her technical expertise encompasses National Health Interview Survey analysis, epidemiological simulations, and program evaluation frameworks.

• Harm Reduction
• Substance Use/Substance Use Disorder
• JEDI Integration in Nursing Education
• +۳ مورد دیگر

Jason R. Lucey is an Assistant Professor and Assistant Dean of Advanced Practice Programs at the MGH Institute of Health Professions (IHP) School of Nursing. He joined the faculty full-time in 2014 after serving as a term lecturer, and has held leadership roles including Family Track Co-Coordinator, Program Director, and Assistant Dean. His clinical background in emergency and urgent care settings has driven his focus on harm reduction and substance use disorder treatment. Lucey has been recognized with awards such as the Nancy T. Watts Award for Excellence in Teaching (2018) and the DAISY Faculty Award (2017). Education: BA in Spanish Literature from College of the Holy Cross (Worcester, MA), MS in Nursing (Family Practice) from MGH IHP, and Doctor of Nursing Practice (University of New Hampshire). Research focuses on integrating harm reduction strategies into healthcare, particularly opioid epidemic response, and advancing JEDI (Justice, Equity, Diversity, Inclusion) principles in nursing education. He advocates for evidence-based care for marginalized populations, including people who use drugs, and has contributed to policy changes like legalizing syringe service programs in New Hampshire. His scholarship emphasizes compassionate care for substance use disorders and improving curricula to address stigmatized health issues. Awards highlight his dedication to teaching and patient advocacy. Professional activities include founding roles in the NH Harm Reduction Coalition and presentations at national conferences on topics like buprenorphine treatment and microaggressions in clinical settings. Labs/Teams: Active in curriculum development for nurse practitioner programs and collaborates with regional health coalitions on harm reduction initiatives.

• Substance Use Disorders
• Harm Reduction
• Integrated Behavioral Healthcare
• +۳ مورد دیگر

Jason Lucey is an Assistant Professor of Nursing and Assistant Dean for Advanced Practice Programs at the MGH Institute of Health Professions (IHP). He holds a Doctor of Nursing Practice from the University of New Hampshire and has been a full-time faculty member since 2014. His roles include overseeing nurse practitioner tracks and advancing substance use disorder education. Dr. Lucey’s clinical background in emergency and urgent care settings drives his commitment to harm reduction, compassionate care for marginalized populations, and policy advocacy. Education: BA in Spanish Literature, College of the Holy Cross MS in Nursing (Family Practice), MGH IHP Doctor of Nursing Practice, University of New Hampshire Research Interests: Dr. Lucey focuses on improving healthcare for people who use substances through harm reduction strategies, integrating JEDI principles into nursing education, and advancing evidence-based practices for opioid use disorder. He emphasizes the need for systemic changes in healthcare and policy to address substance use as a public health issue rather than a criminal one. Grants & Awards: Nancy T. Watts Award for Excellence in Teaching (2018) DAISY Faculty Award (2017) Substance Use Disorder Champion in Action Award (2016) Labs & Initiatives: Co-founder of the New Hampshire Harm Reduction Coalition, advocating for syringe service programs and overdose prevention. Currently leading curriculum development in substance use training at MGH IHP.

• HIV/AIDS Medicine
• Addiction Medicine
• Implementation Science
• +۷ مورد دیگر

Frederick Lewis Altice is a Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases) at Yale School of Medicine, with affiliations at the Yale Institute for Global Health and the University of Malaya. He directs the Yale Center for Clinical and Community Research and the HIV in Prisons Program. His work focuses on the intersection of infectious diseases, substance use disorders, and criminal justice systems, emphasizing implementation science and global health equity. Education: MD, Emory University (1986) Residency and Fellowship, Yale University School of Medicine (1989–1992) MA in Spanish Literature, Universidad de Santiago de Compostela (1982) MA (Honorary), Yale University (2008) Research Interests: Dr. Altice’s research integrates HIV/AIDS treatment, addiction medicine, and public health interventions. Key areas include medication-assisted therapies (methadone, buprenorphine), HIV prevention in prisons, opioid use disorder management, and scaling evidence-based interventions in low-resource settings. His global projects span Malaysia, Ukraine, Peru, and Eastern Europe, with a focus on implementation science and health system strengthening. Articles Overview: Recent work emphasizes PrEP adherence among opioid users, stigma reduction in healthcare, and HIV care integration in criminal justice systems. His studies highlight innovative strategies like mobile health tools and ECHO-like collaborative learning networks to improve treatment access. Awards: 2016 Most Influential Paper on Addictions (Lancet) National 'Hope is a Vaccine' Award (2008) Academic Icon Professor at University of Malaya Grants & Labs: Leads major initiatives funded by NIDA, Fogarty, and WHO, including the Malaysian Center for Implementation Science and Ukraine’s prison HIV prevention programs. His labs focus on clinical and community research, with collaborations in global health equity training programs.